Vicarious Surgical (RBOT) Common Equity (2020 - 2025)

Vicarious Surgical (RBOT) has 6 years of Common Equity data on file, last reported at $9.8 million in Q4 2025.

• On a quarterly basis, Common Equity fell 78.93% year-over-year to $9.8 million in Q4 2025; TTM through Dec 2025 was $9.8 million, a 78.93% decrease from a year earlier, with the FY2025 full-year figure at $9.8 million, down 78.93% from the prior year.
• Common Equity for Q4 2025 stood at $9.8 million, down from $14.1 million in the prior quarter.
• Over the last five years, Common Equity for RBOT reached as high as $129.8 million in Q2 2022 and fell as low as -$40.9 million in Q2 2021.
• Historically, Common Equity has averaged $62.7 million across 5 years, with a median of $73.8 million in 2023.
• Across the five-year window, Common Equity surged 469.16% in 2022 and slumped 78.93% in 2025, its largest moves.
• Year by year, Common Equity stood at $83.1 million in 2021, then surged by 33.64% to $111.0 million in 2022, then decreased by 11.78% to $98.0 million in 2023, then sank by 52.33% to $46.7 million in 2024, then slumped by 78.93% to $9.8 million in 2025.
• Per Business Quant data, the three most recent Common Equity figures were $9.8 million in Q4 2025, $14.1 million in Q3 2025, and $23.1 million in Q2 2025.